These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 6425910

  • 1. Tranylcypromine vs nortriptyline vs placebo in depressed outpatients: a controlled trial.
    White K, Razani J, Cadow B, Gelfand R, Palmer R, Simpson G, Sloane RB.
    Psychopharmacology (Berl); 1984; 82(3):258-62. PubMed ID: 6425910
    [Abstract] [Full Text] [Related]

  • 2. A double-blind study of tranylcypromine treatment of major anergic depression.
    Himmelhoch JM, Fuchs CZ, Symons BJ.
    J Nerv Ment Dis; 1982 Oct; 170(10):628-34. PubMed ID: 7050302
    [Abstract] [Full Text] [Related]

  • 3. The clinical efficacy and side-effects of mianserin and nortriptyline in depressed out-patients: a double-blind randomized trial.
    Hoc J.
    Curr Med Res Opin; 1982 Oct; 8(4):282-9. PubMed ID: 6759061
    [Abstract] [Full Text] [Related]

  • 4. A placebo-controlled comparison of the effect of nortriptyline and phenelzine on orthostatic hypotension in elderly depressed patients.
    Georgotas A, McCue RE, Friedman E, Cooper TB.
    J Clin Psychopharmacol; 1987 Dec; 7(6):413-6. PubMed ID: 3323263
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and tolerability of tranylcypromine versus phenelzine: a double-blind study in antidepressant-refractory depressed inpatients.
    Birkenhäger TK, van den Broek WW, Mulder PG, Bruijn JA, Moleman P.
    J Clin Psychiatry; 2004 Nov; 65(11):1505-10. PubMed ID: 15554763
    [Abstract] [Full Text] [Related]

  • 6. A clinical trial comparing nomifensine and nortriptyline.
    Pöldinger W, Streichenwein SM.
    Int Pharmacopsychiatry; 1982 Nov; 17 Suppl 1():106-15. PubMed ID: 6752077
    [Abstract] [Full Text] [Related]

  • 7. MAOIs in the contemporary treatment of depression.
    Thase ME, Trivedi MH, Rush AJ.
    Neuropsychopharmacology; 1995 May; 12(3):185-219. PubMed ID: 7612154
    [Abstract] [Full Text] [Related]

  • 8. Factors affecting the delay of antidepressant effect in responders to nortriptyline and phenelzine.
    Georgotas A, McCue RE, Cooper TB, Nagachandran N, Friedhoff A.
    Psychiatry Res; 1989 Apr; 28(1):1-9. PubMed ID: 2662234
    [Abstract] [Full Text] [Related]

  • 9. Treatment of melancholia with tranylcypromine.
    McGrath PJ, Quitkin FM, Harrison W, Stewart JW.
    Am J Psychiatry; 1984 Feb; 141(2):288-9. PubMed ID: 6691499
    [Abstract] [Full Text] [Related]

  • 10. Brofaromine in non-endogenous major depressed inpatients--results of a preliminary dose-finding trial versus tranylcypromine.
    Volz HP, Heimann H, Bellaire J, Laux G, Möller HJ.
    Pharmacopsychiatry; 1994 Jul; 27(4):152-8. PubMed ID: 7972347
    [Abstract] [Full Text] [Related]

  • 11. [Comparison of the effectiveness of tranylcypromine, nortriptyline, thioridazine and amitriptyline in two syndromological types of endogenous depression (author's transl)].
    Náhunek K, Svestka J, Cesková E, Rysánek R, Novotná H.
    Cesk Psychiatr; 1981 Jul; 77(4):245-52. PubMed ID: 7318002
    [No Abstract] [Full Text] [Related]

  • 12. Brofaromine in treatment-resistant depressed patients--a comparative trial versus tranylcypromine.
    Volz HP, Faltus F, Magyar I, Möller HJ.
    J Affect Disord; 1994 Mar; 30(3):209-17. PubMed ID: 8006247
    [Abstract] [Full Text] [Related]

  • 13. Tranylcypromine isomers in depressed outpatients: effects on depression, monoamine oxidase inhibition and tyramine pressor response.
    Van de Merwe TJ, Pare CM, Glover V, Sandler M.
    Mod Probl Pharmacopsychiatry; 1983 Mar; 19():189-202. PubMed ID: 6346066
    [No Abstract] [Full Text] [Related]

  • 14. The safety and efficacy of combined amitriptyline and tranylcypromine antidepressant treatment. A controlled trial.
    Razani J, White KL, White J, Simpson G, Sloane RB, Rebal R, Palmer R.
    Arch Gen Psychiatry; 1983 Jun; 40(6):657-61. PubMed ID: 6342565
    [Abstract] [Full Text] [Related]

  • 15. Therapeutic and side-effect profile of a selective and reversible MAO-A inhibitor, brofaromine. Results of dose-finding trials in depressed patients.
    Schiwy W, Heath WR, Delini-Stula A.
    J Neural Transm Suppl; 1989 Jun; 28():33-44. PubMed ID: 2677240
    [Abstract] [Full Text] [Related]

  • 16. Treatment of imipramine-resistant recurrent depression, IV: A double-blind crossover study of tranylcypromine for anergic bipolar depression.
    Thase ME, Mallinger AG, McKnight D, Himmelhoch JM.
    Am J Psychiatry; 1992 Feb; 149(2):195-8. PubMed ID: 1734739
    [Abstract] [Full Text] [Related]

  • 17. Differences in effect between nomifensine and nortriptyline.
    Pöldinger W, Gammel G.
    Int Pharmacopsychiatry; 1978 Feb; 13(1):58-68. PubMed ID: 342438
    [Abstract] [Full Text] [Related]

  • 18. Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial.
    Lustman PJ, Griffith LS, Clouse RE, Freedland KE, Eisen SA, Rubin EH, Carney RM, McGill JB.
    Psychosom Med; 1997 Feb; 59(3):241-50. PubMed ID: 9178335
    [Abstract] [Full Text] [Related]

  • 19. Nortriptyline treatment of post-stroke depression: a double-blind study.
    Lipsey JR, Robinson RG, Pearlson GD, Rao K, Price TR.
    Lancet; 1984 Feb 11; 1(8372):297-300. PubMed ID: 6141377
    [Abstract] [Full Text] [Related]

  • 20. Comparative efficacy and safety of MAOIs versus TCAs in treating depression in the elderly.
    Georgotas A, McCue RE, Hapworth W, Friedman E, Kim OM, Welkowitz J, Chang I, Cooper TB.
    Biol Psychiatry; 1986 Oct 11; 21(12):1155-66. PubMed ID: 3756264
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.